Fox Chase Cancer Center’s Jaye Gardiner Receives Research Grant From Uplifting Athletes

Thumbnail
Jaye Gardiner, PhD, postdoctoral fellow at Fox Chase Cancer Center.

PHILADELPHIA (March 19, 2025) — Jaye Gardiner, PhD, a postdoctoral fellow at Fox Chase Cancer Center, was one of 10 rare disease researchers to receive a grant from the nonprofit Uplifting Athletes during its Young Investigators Draft.

“I’m very honored to receive this grant, which will help me continue and enhance my work,” said Gardiner, who conducts her research in the lab of Edna “Eti” Cukierman, PhD, Co-Director of the Marvin and Concetta Greenberg Pancreatic Cancer Institute at Fox Chase.

Gardiner’s research focuses on the tumor microenvironment (TME), which consists of the cells in the immediate vicinity of cancer cells. Gardiner said the TME plays a key role in the growth of tumors in pancreatic ductal adenocarcinoma, in part by maintaining an immunosuppressive environment that allows tumors to grow.

“It is an honor to partner with 10 patient advocacy organizations to advance rare disease research, and we are overjoyed to celebrate the 2025 Draft Class,” said Brett Brackett, President of Uplifting Athletes. “These 10 incredible researchers represent so much promise for tomorrow, and we are honored to have them on our team.”

Uplifting Athletes is a nonprofit organization that unites student-athletes and professional athlete ambassadors nationwide with their local rare disease communities. Together, they raise awareness, inspire hope, and generate funds to support the approximately 1 in 10 Americans impacted by rare diseases. Over $1 million in grants have been awarded throughout the program’s history.  

The Young Investigator Draft is inspired by the NFL Draft but shifts the focus from selecting potential talent on the football field to recognizing the next generation of promising young medical researchers in rare diseases. It is one of several signature initiatives created by Uplifting Athletes to raise awareness and research funding for rare diseases, which affect approximately 30 million individuals in the United States.

Grant submissions for the Young Investigator Draft are evaluated by an expert panel of scientific advisors prior to the selection of each year’s Draft Class. Every researcher is nominated by a patient advocacy organization recognized by Uplifting Athletes as a priority partner. The grants are equally co-funded by Uplifting Athletes and the nominating organization, which in Gardiner’s case was the Pancreatic Cancer Cure Foundation.

Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence six consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

For more information, call 888-369-2427